Liminatus Pharma Inc.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol LIMN:xnas
Currency USD
NASDAQ
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Liminatus Pharma Inc.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
Sector Healthcare
Industry Oncology Biopharmaceuticals
Market Cap 0.038161086bn
Data provided by 
/ 
/